Kurt Einarsson
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms
Papers in
- Co-authors
- Bo Angelin (84 shared papers)S Ewerth (33 shared papers)Kjell Hellström (28 shared papers)Barbro Leijd (26 shared papers)Ingemar Björkhem (21 shared papers)Ingemar Björkhem (41 shared papers)Eva Reihnér (24 shared papers)K Nilsell (15 shared papers)
- Journals
- Journal of Lipid Research (30 papers)European Journal of Clinical Investigation (17 papers)Gut (15 papers)Gastroenterology (14 papers)Scandinavian Journal of Gastroenterology (12 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Kurt Einarsson
229 papers receiving 7.5k citations
Peers
Comparison fields: 5 of 128
- Pharmacology 1.1k
- Oncology 3.1k
- Surgery 4.0k
- Clinical Biochemistry 592
- Endocrinology, Diabetes and Metabolism 1.4k
Countries citing papers authored by Kurt Einarsson
This map shows the geographic impact of Kurt Einarsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Einarsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Einarsson more than expected).
Fields of papers citing papers by Kurt Einarsson
This network shows the impact of papers produced by Kurt Einarsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Einarsson. The network helps show where Kurt Einarsson may publish in the future.
Co-authors
The 25 scholars most cited alongside Kurt Einarsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 229 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 252 | |
| 2 | 1987 | 250 | |
| 3 | 1967 | 248 | |
| 4 | 1985 | 223 | |
| 5 | 1973 | 223 | |
| 6 | 1982 | 199 | |
| 7 | 1978 | 158 | |
| 8 | 1996 | 146 | |
| 9 | 1983 | 145 | |
| 10 | 1991 | 139 | |
| 11 | 1991 | 135 | |
| 12 | 1974 | 115 | |
| 13 | 1982 | 113 | |
| 14 | 1977 | 112 | |
| 15 | 1991 | 106 | |
| 16 | 1989 | 103 | |
| 17 | 1987 | 99 | |
| 18 | 1986 | 97 | |
| 19 | 1990 | 95 | |
| 20 | 1992 | 91 |
About Kurt Einarsson
Kurt Einarsson is a scholar working on Oncology, Surgery, Epidemiology, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 229 papers that have together received 8.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (104 papers), Cholesterol and Lipid Metabolism (54 papers), Liver Disease Diagnosis and Treatment (51 papers), Pharmacogenetics and Drug Metabolism (36 papers), Metabolism and Genetic Disorders (27 papers), Pediatric Hepatobiliary Diseases and Treatments (19 papers), Gallbladder and Bile Duct Disorders (19 papers) and Hormonal and reproductive studies (16 papers). The work is most often cited by research in Pharmacology (1.1k citations), Oncology (3.1k citations), Surgery (4.0k citations), Clinical Biochemistry (592 citations) and Endocrinology, Diabetes and Metabolism (1.4k citations). Kurt Einarsson has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Bo Angelin, S Ewerth, Kjell Hellström, Barbro Leijd, Ingemar Björkhem, Ingemar Björkhem, Eva Reihnér, K Nilsell, Jan-Ακε Gustafsson and Henry Danielsson. Their work appears in journals such as Journal of Lipid Research, European Journal of Clinical Investigation, Gut, Gastroenterology and Scandinavian Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.